A8SGLP-1 (trifluoroacetate salt)

A peptide agonist of GLP-1R and a derivative of GLP-1 (7-36) amide

Catalog Number 41264
Research Area Product Type|Biochemicals|Peptides||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes
Molecular Formula C151H229N41O47 • XCF3COOH
CAS# 753024-08-7
Purity ≥98%
Inchi InChI=1S/C151H229N41O47.C2HF3O2/c1-16-77(10)121(148(237)169-80(13)126(215)177-104(59-86-62-161-91-35-24-23-34-89(86)91)137(226)179-100(55-74(4)5)138(227)189-119(75(6)7)146(235)176-93(36-25-27-51-152)129(218)163-65-112(202)170-92(38-29-53-160-151(157)158)128(217)162-64-111(156)201)191-139(228)102(56-83-30-19-17-20-31-83)180-134(223)98(46-50-117(209)210)175-133(222)94(37-26-28-52-153)172-125(214)79(12)167-124(213)78(11)168-132(221)97(43-47-110(155)200)171-113(203)66-164-130(219)95(44-48-115(205)206)173-135(224)99(54-73(2)3)178-136(225)101(58-85-39-41-88(199)42-40-85)181-143(232)107(69-194)185-145(234)109(71-196)186-147(236)120(76(8)9)190-141(230)105(61-118(211)212)182-144(233)108(70-195)187-150(239)123(82(15)198)192-140(229)103(57-84-32-21-18-22-33-84)183-149(238)122(81(14)197)188-114(204)67-165-131(220)96(45-49-116(207)208)174-142(231)106(68-193)184-127(216)90(154)60-87-63-159-72-166-87;3-2(4,5)1(6)7/h17-24,30-35,39-42,62-63,72-82,90,92-109,119-123,161,193-199H,16,25-29,36-38,43-61,64-71,152-154H2,1-15H3,(H2,155,200)(H2,156,201)(H,159,166)(H,162,217)(H,163,218)(H,164,219)(H,165,220)(H,167,213)(H,168,221)(H,169,237)(H,170,202)(H,171,203)(H,172,214)(H,173,224)(H,174,231)(H,175,222)(H,176,235)(H,177,215)(H,178,225)(H,179,226)(H,180,223)(H,181,232)(H,182,233)(H,183,238)(H,184,216)(H,185,234)(H,186,236)(H,187,239)(H,188,204)(H,189,227)(H,190,230)(H,191,228)(H,192,229)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,157,158,160);(H,6,7)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,119-,120-,121-,122-,123-;/m0./s1
Inchi Key BUWALRGZBJHKDN-QPCGZRJISA-N
SMILES [H]N[C@@H](CC1=CN=CN1)C(N[C@H](C(N[C@H](C(NCC(N[C@]([H])(C(N[C@@H](CC2=CC=CC=C2)C(N[C@]([H])(C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@@H](C)C(N[C@@H](C)C(N[C@H](C(N[C@H](C(N[C@@H](CC4=CC=CC=C4)C(N[C@]([H])(C(N[C@@H](C)C(N[C@@H](CC5=CNC6=C5C=CC=C6)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N)=O)=O)CCCNC(N)=N)=O)=O)CCCCN)=O)C(C)C)=O)CC(C)C)=O)=O)=O)[C@@H](C)CC)=O)=O)CCC(O)=O)=O)CCCCN)=O)=O)=O)CCC(N)=O)=O)=O)CCC(O)=O)=O)CC(C)C)=O)=O)CO)=O)CO)=O)C(C)C)=O)=O)CO)=O)[C@H](O)C)=O)=O)[C@H](O)C)=O)=O)CCC(O)=O)=O)CO)=O.O=C(O)C(F)(F)F
Size 5 mg
Supplier Page https://www.caymanchem.com/product/41264